7.3.6	  Summary of evidence and guidelines for multimodal treatment in advanced urethral   carcinoma in both males and females,
Recommendations,Strength rating
Offer a urethra-sparing approach with transurethral resection (TUR) and bacillus-Calmette   Gu√©rin (BCG) to patients with non-invasive urethral carcinoma or carcinoma in situ of the   prostatic urethra and prostatic ducts.,Strong
"In patients not responding to BCG, or in patients with extensive ductal or stromal   involvement, perform a cystoprostatectomy with extended pelvic lymphadenectomy.",Weak
